kynurenic acid has been researched along with Atherogenesis in 4 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aim To compare serum concentrations of tryptophane (Trp) and its metabolites in subjects with no cardiovascular disease (CVD) and patients with СVD, including arterial hypertension (AH) and ischemic heart disease (IHD)." | 8.12 | Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease. ( Ageev, AA; Appolonova, SA; Belenkov, YN; Korobkova, EO; Kozhevnikova, MV; Krivova, AV; Moskaleva, NE; Privalova, EV; Shestakova, KM, 2022) |
| " Thus, we studied the correlations of aortic stiffness and echocardiographic parameters with biochemical markers and serum level of kynurenic acid (KYNA), an endothelial derivative of tryptophan, formed along the kynurenine pathway, among patients with atrial fibrillation (AF)." | 7.96 | Aortic stiffness-Is kynurenic acid a novel marker? Cross-sectional study in patients with persistent atrial fibrillation. ( Kamińska, A; Kocki, T; Urbanska, EM; Wysokiński, A; Zapolski, T, 2020) |
| "Aim To compare serum concentrations of tryptophane (Trp) and its metabolites in subjects with no cardiovascular disease (CVD) and patients with СVD, including arterial hypertension (AH) and ischemic heart disease (IHD)." | 4.12 | Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease. ( Ageev, AA; Appolonova, SA; Belenkov, YN; Korobkova, EO; Kozhevnikova, MV; Krivova, AV; Moskaleva, NE; Privalova, EV; Shestakova, KM, 2022) |
| " Thus, we studied the correlations of aortic stiffness and echocardiographic parameters with biochemical markers and serum level of kynurenic acid (KYNA), an endothelial derivative of tryptophan, formed along the kynurenine pathway, among patients with atrial fibrillation (AF)." | 3.96 | Aortic stiffness-Is kynurenic acid a novel marker? Cross-sectional study in patients with persistent atrial fibrillation. ( Kamińska, A; Kocki, T; Urbanska, EM; Wysokiński, A; Zapolski, T, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kozhevnikova, MV | 2 |
| Krivova, AV | 2 |
| Korobkova, EO | 2 |
| Ageev, AA | 2 |
| Shestakova, KM | 2 |
| Moskaleva, NE | 2 |
| Appolonova, SA | 2 |
| Privalova, EV | 2 |
| Belenkov, YN | 2 |
| Zapolski, T | 1 |
| Kamińska, A | 1 |
| Kocki, T | 1 |
| Wysokiński, A | 1 |
| Urbanska, EM | 1 |
| Metghalchi, S | 1 |
| Ponnuswamy, P | 1 |
| Simon, T | 1 |
| Haddad, Y | 1 |
| Laurans, L | 1 |
| Clément, M | 1 |
| Dalloz, M | 1 |
| Romain, M | 1 |
| Esposito, B | 1 |
| Koropoulis, V | 1 |
| Lamas, B | 1 |
| Paul, JL | 1 |
| Cottin, Y | 1 |
| Kotti, S | 1 |
| Bruneval, P | 1 |
| Callebert, J | 1 |
| den Ruijter, H | 1 |
| Launay, JM | 1 |
| Danchin, N | 1 |
| Sokol, H | 1 |
| Tedgui, A | 1 |
| Taleb, S | 1 |
| Mallat, Z | 1 |
| Nowicka-Stążka, P | 1 |
| Stążka, K | 1 |
| Dąbrowski, W | 1 |
| Turski, W | 1 |
| Majdan, M | 1 |
| Parada-Turska, J | 1 |
1 review available for kynurenic acid and Atherogenesis
| Article | Year |
|---|---|
[Kynurenic acid--a new tool in the treatment of hiperhomocysteinemia and its consequences?].
Topics: Atherosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; | 2012 |
3 other studies available for kynurenic acid and Atherogenesis
| Article | Year |
|---|---|
Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease.
Topics: Atherosclerosis; Coronary Artery Disease; Humans; Hydroxyindoleacetic Acid; Hypertension; Kynurenic | 2022 |
Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease.
Topics: Atherosclerosis; Coronary Artery Disease; Humans; Hydroxyindoleacetic Acid; Hypertension; Kynurenic | 2022 |
Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease.
Topics: Atherosclerosis; Coronary Artery Disease; Humans; Hydroxyindoleacetic Acid; Hypertension; Kynurenic | 2022 |
Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease.
Topics: Atherosclerosis; Coronary Artery Disease; Humans; Hydroxyindoleacetic Acid; Hypertension; Kynurenic | 2022 |
Aortic stiffness-Is kynurenic acid a novel marker? Cross-sectional study in patients with persistent atrial fibrillation.
Topics: Adult; Aorta; Atherosclerosis; Atrial Fibrillation; Biomarkers; Cross-Sectional Studies; Echocardiog | 2020 |
Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production.
Topics: Animals; Atherosclerosis; Colitis; Female; Gene Deletion; Humans; Immunity; Indoleamine-Pyrrole 2,3, | 2015 |